
Acorda Therapeutics ACOR
Quarterly report 2024-Q1
added 05-14-2024
Acorda Therapeutics PEG Ratio 2011-2026 | ACOR
Annual PEG Ratio Acorda Therapeutics
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -0.000047 | 0.00311 | 0.000199 | -0.00851 | 0.000411 | 0.2 | 0.0101 | 0.0653 | -3.56 | 19.8 | -0.819 | 0.0182 | 0.0927 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 19.8 | -3.56 | 1.22 |
PEG Ratio of other stocks in the Biotechnology industry
| Issuer | PEG Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
MorphoSys AG
MOR
|
-0.169 | - | 2.43 % | $ 254 M | ||
|
AgeX Therapeutics
AGE
|
-0.51 | - | -10.17 % | $ 12.2 K | ||
|
BioNTech SE
BNTX
|
-12.8 | $ 97.54 | -5.71 % | $ 27.2 B | ||
|
I-Mab
IMAB
|
-0.75 | - | - | $ 866 M | ||
|
Akero Therapeutics
AKRO
|
-0.964 | - | - | $ 3.67 B | ||
|
Burford Capital Limited
BUR
|
-0.568 | $ 5.2 | 5.69 % | $ 820 M | ||
|
Midatech Pharma plc
MTP
|
-0.0114 | - | -18.52 % | $ 27.3 M | ||
|
AlloVir
ALVR
|
0.1 | - | 4.14 % | $ 49.1 M | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
-0.747 | - | - | $ 40.3 B | ||
|
Genfit SA
GNFT
|
-0.0281 | - | 2.54 % | $ 160 B | ||
|
Cerus Corporation
CERS
|
0.951 | $ 2.72 | 33.99 % | $ 518 M | ||
|
ACADIA Pharmaceuticals
ACAD
|
-0.144 | $ 21.95 | -2.23 % | $ 3.64 B | ||
|
EyeGate Pharmaceuticals, Inc.
EYEG
|
0.254 | - | -1.52 % | $ 24.7 M | ||
|
Athira Pharma
ATHA
|
0.0276 | - | - | $ 269 M | ||
|
Applied Molecular Transport
AMTI
|
0.133 | - | - | $ 10.1 M | ||
|
Ayala Pharmaceuticals
AYLA
|
0.0783 | - | - | $ 7.46 M | ||
|
AstraZeneca PLC
AZN
|
-369 | - | - | $ 96.9 B | ||
|
Atreca
BCEL
|
0.187 | - | -11.76 % | $ 5.79 M | ||
|
Berkeley Lights
BLI
|
0.863 | - | -7.31 % | $ 87 M | ||
|
Calithera Biosciences
CALA
|
-1.33 | - | -10.95 % | $ 876 K | ||
|
Advaxis
ADXS
|
-0.000022 | - | -9.65 % | $ 45.9 M | ||
|
CymaBay Therapeutics
CBAY
|
-24.1 | - | - | $ 3.45 B | ||
|
ChemoCentryx
CCXI
|
-0 | - | - | $ 3.74 B | ||
|
Институт стволовых клеток человека
ISKJ
|
-2.8 | - | - | - | ||
|
Cardiff Oncology
CRDF
|
0.185 | $ 1.71 | -1.16 % | $ 114 M | ||
|
Caladrius Biosciences
CLBS
|
-0.00197 | - | -16.75 % | $ 25.8 M | ||
|
Checkmate Pharmaceuticals
CMPI
|
0.189 | - | - | $ 231 M | ||
|
Aeterna Zentaris
AEZS
|
0.0493 | - | 5.93 % | $ 314 M | ||
|
Brainstorm Cell Therapeutics
BCLI
|
-0.00304 | - | -2.5 % | $ 5.88 M | ||
|
Aeglea BioTherapeutics
AGLE
|
-0.0134 | - | - | $ 1.01 B | ||
|
Applied Genetic Technologies Corporation
AGTC
|
0.00894 | - | - | $ 26.5 M | ||
|
Deciphera Pharmaceuticals
DCPH
|
1.4 | - | - | $ 2.18 B | ||
|
AIkido Pharma
AIKI
|
-0.000778 | - | 1.93 % | $ 17.4 M | ||
|
Editas Medicine
EDIT
|
-1.63 | $ 2.9 | -3.33 % | $ 257 M | ||
|
Dynavax Technologies Corporation
DVAX
|
-0.688 | - | - | $ 2.02 B | ||
|
Edesa Biotech
EDSA
|
-0.0119 | $ 17.59 | -3.75 % | $ 56.2 M | ||
|
Akouos
AKUS
|
0.105 | - | 0.23 % | $ 488 M | ||
|
Allakos
ALLK
|
0.664 | - | - | $ 28.6 M | ||
|
Can-Fite BioPharma Ltd.
CANF
|
-0.000013 | $ 2.93 | -8.15 % | $ 4.82 M | ||
|
Eiger BioPharmaceuticals
EIGR
|
-0.000075 | - | -9.21 % | $ 2.55 M | ||
|
Eloxx Pharmaceuticals
ELOX
|
-0.000198 | - | -5.68 % | $ 8.28 M | ||
|
CureVac N.V.
CVAC
|
4.05 | - | - | $ 867 M | ||
|
Ampio Pharmaceuticals
AMPE
|
-0.000293 | - | -11.43 % | $ 502 K | ||
|
Applied Therapeutics
APLT
|
0.243 | - | - | $ 8.42 M | ||
|
Aptose Biosciences
APTO
|
-0.000164 | - | -45.71 % | $ 1.2 M | ||
|
Aptinyx
APTX
|
-0.0809 | - | -39.0 % | $ 4.57 M | ||
|
Evogene Ltd.
EVGN
|
-1.63 | $ 0.81 | 3.33 % | $ 27.9 M | ||
|
Aravive
ARAV
|
0.0342 | - | -13.39 % | $ 1.45 M | ||
|
Aridis Pharmaceuticals
ARDS
|
-7.82 | - | 17.91 % | $ 11.1 M |